SCIESCOPUSQ1
Molecular Therapy Oncology
CELL PRESS, United States
Molecular Therapy Oncology is an academic journal published by CELL PRESS (United States). Identifiers: eISSN 2950-3299. Indexed in SCIE, SCOPUS. Metrics: JIF 5.3, CiteScore 11.1, SJR 1.716, SNIP 0.94. Subject areas: MEDICINE, ONCOLOGY, RESEARCH & EXPERIMENTAL. tlooto lists 741 papers from this journal.
CiteScore
11.10
Scopus citation metric
SJR
1.716
SCImago rank
SNIP
0.94
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2950-3299
- Abbreviation
- MOL THER ONCOL
- Publisher
- CELL PRESS
- Country
- United States
Web of Science categories
SCIEMEDICINE, ONCOLOGY, RESEARCH & EXPERIMENTAL
Scopus ASJC categories
1306 Cancer Research1313 Molecular Medicine2730 Oncology2736 Pharmacology (medical)
Papers in this journal
Recent papers
- Nanobody-engineered CLL-1 CAR T cells: A strategy for safer targeting in acute myeloid leukemia
2026
- CBX6 and CA9 as predictive indicators and therapeutic targets in GBM
2026
- Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506
2026
- The miR-16-1-3p suppresses proliferation and invasiveness via the MDM2-p53 axis in TGF-β1 signaling in osteosarcoma
2026
- Enhancing immunotherapy efficacy of hepatocellular carcinoma by inhibiting the key antioxidant factor Nrf2
2026
Most cited papers
- Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party
2024 · 62 citations
- Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma
2024 · 41 citations
- Cost-effective strategies for CAR-T cell therapy manufacturing
2025 · 31 citations
- Emerging delivery strategy for oncolytic virotherapy
2024 · 31 citations
- TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
2024 · 27 citations